GENIUS PROFESSIONAL SERVICES LIMITED

Financial Health Score: F (Critical/Terminal)

This business has suffered a catastrophic financial collapse. With the company currently in Liquidation, the patient has, unfortunately, passed away. The financial statements from 2021 show a business on life support, and the subsequent failure to file accounts and the move into Liquidation confirm that the vital organs have ceased functioning.

1. Key Vital Signs

Pulse (Cash Position): £1,729 The patient's pulse is barely registering. Cash has haemorrhaged from £44,090 in 2017 to just £1,729 in 2021. This is a clear sign of severe financial anemia; the business has virtually no liquid reserves to sustain daily operations or respond to emergencies.

Blood Pressure (Liquidity): -£1,005,164 Net Current Liabilities The circulatory system is under immense strain. Current liabilities (£1.31 million) vastly exceed current assets (£309,726), resulting in massive negative working capital. The business owes far more in short-term debts than it can possibly pay, a classic symptom of imminent cardiac arrest in a corporate entity.

Weight (Net Assets): -£1,004,458 The company is morbidly obese with debt. Net assets have plummeted from a healthy £50,483 in 2017 to a deficit of over £1 million in 2021. The equity has been entirely consumed by accumulated losses, leaving the business deeply insolvent on paper.

Temperature (Profitability): Chronic Losses The business has been running a chronic fever of unprofitability. It recorded a loss of £231,021 in 2021, following a loss of £284,587 in 2020. This persistent bleeding of capital has been the primary cause of the deteriorating health.

Cholesterol (Debt Structure): £1,166,300 Shareholder Loan The largest blockage in the arteries is a loan from the parent company, BMN GP Limited. While this loan was keeping the heart pumping (the directors relied on it for going concern status in 2021), it was repayable on demand and represented an unstable foundation for long-term health.

2. Symptoms Analysis

The financial data reveals a patient that has been gravely ill for several years:

• The Life Support Illusion: In the 2021 accounts, the directors argued that the company was a "going concern" solely because the shareholder (BMN GP Limited) had indicated they would not demand repayment of the £1.16m loan. However, relying on an informal promise for a loan repayable on demand is like relying on a respirator that could be unplugged at any moment.
• Phantom Health (Deferred Tax Asset): The debtors include a £246,949 "deferred tax asset." This is essentially a tax relief that can only be used if the company makes future profits. Given the terminal state of the business, this asset is a phantom—it will never be realised and offers no real nutritional value to the patient.
• Regulatory Immune Deficiency: The company's accounts are overdue, and its confirmation statement is overdue. This failure to maintain basic administrative hygiene suggests the corporate immune system has completely shut down, which is consistent with the company entering Liquidation.

3. Diagnosis

Terminal Insolvency and Organ Failure.

The patient has expired. The progression from a positive net asset position in 2017 to a deficit exceeding £1 million by 2021 shows a rapid and aggressive disease. The reliance on a single, demand-repayable shareholder loan was the only thing preventing rigor mortis from setting in during 2021.

The fact that the company is now in Liquidation confirms that the shareholder support was either withdrawn or deemed insufficient to cover the escalating liabilities. The "going concern" prognosis made by the directors in February 2022 has proven to be fatally optimistic. The business is no longer a going concern; it is being dissected for the value of its remaining parts.

4. Recommendations

As the company is in Liquidation, the focus shifts from curing the patient to conducting a post-mortem and managing the estate:

1. Cease All Trading Immediately: Any continued trading would be akin to trying to resuscitate a corpse and could lead to wrongful trading allegations against the directors.
2. Cooperate with the Liquidator: The directors must provide full transparency and hand over all books and records to the appointed liquidator. This is the legal equivalent of authorising an autopsy.
3. Asset Realisation: The liquidator will focus on extracting any remaining value, primarily from the £307,997 owed by debtors. However, given the nature of the debtors (including the likely uncollectable deferred tax asset), the return to creditors will be minimal.
4. Creditor Communication: Creditors should be prepared for a significant loss. The secured creditor (BMN GP Limited) will likely take precedence, leaving unsecured trade creditors with little to no recovery.